Nathan A. Ledeboer, PhD
Professor; Medical Director, Clinical Microbiology; Medical Director, Molecular Diagnostics
Locations
- Pathology & Laboratory Medicine
Contact Information
Biography
Dr. Ledeboer’s primary responsibility is for the medical and technical oversight of the Clinical Microbiology and Molecular Diagnostics Laboratories. In this role he oversees development and implementation of new assays, oversees and sign out all testing performed in these laboratories, and consults with physician colleagues regarding test results and selection.
Specialties:
- Clinical Microbiology
- Molecular Pathology
Research Interests
Development of rapid molecular techniques for detection of infectious diseases
Host Response to Infection
Combining Digital Imaging and Artificial Intelligence
Molecular detection and epidemiology of Respiratory Viruses
Antimicrobial resistance
Publications
-
(Sheybani R, O'Neal HR Jr, Thomas CB, Scoggins R, Pfaff C, Smithline H, Wolk DM, Melnychuk E, Aufderheide TP, Carver T, Chinn M, Ledeboer NA, Kraus CK.) J Am Coll Emerg Physicians Open. 2026 Jun;7(3):100358 PMID: 41952794 PMCID: PMC13054420 SCOPUS ID: 2-s2.0-105033869500 04/09/2026
-
(Sheikh MM, Attar H, Book D, Corrao K, Cunningham A, Field JJ, Foy P, Harrington AM, Janssen J, Jung B, Kolinski J, Ledeboer N, McIntosh J, Singh S, Baumann Kreuziger L.) Thromb Res. 2026 Mar;259:109632 PMID: 41762930 SCOPUS ID: 2-s2.0-105033508034 03/01/2026
-
(Munoz-Price LS, Atkinson SN, Lam V, Buchan B, Ledeboer N, Salzman NH, Pan AY.) Microorganisms. 2025 Sep 29;13(10) PMID: 41156737 PMCID: PMC12566496 SCOPUS ID: 2-s2.0-105020085967 10/29/2025
-
(Petroll A, Woodbury J, Chin M, Ledeboer N, Rubin J, Zakzesky D, Martin I.) WMJ. 2025;124(2):157-161 PMID: 40690637 SCOPUS ID: 2-s2.0-105011961631 07/21/2025
-
(Paradis S, Van Der Pol B, Kaatz NA, Davis TE, Ledeboer NA, Faron ML, Laviers W, Lockamy E, Yanson KA.) Diagn Microbiol Infect Dis. 2024 Nov;110(3):116482 PMID: 39142094 SCOPUS ID: 2-s2.0-85201109760 08/15/2024
-
Review: Known, Emerging, and Remerging Pharyngitis Pathogens.
(Caldwell JM, Ledeboer NA, Boyanton BL Jr.) J Infect Dis. 2024 Oct 23;230(Supplement_3):S173-S181 PMID: 39441194 PMCID: PMC11497846 SCOPUS ID: 2-s2.0-85207598934 10/23/2024
-
Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers.
(Ledeboer NA, Caldwell JM, Boyanton BL Jr.) J Infect Dis. 2024 Oct 23;230(Supplement_3):S190-S196 PMID: 39441193 PMCID: PMC11497841 SCOPUS ID: 2-s2.0-85207597355 10/23/2024
-
Review: Current Laboratory and Point-of-Care Pharyngitis Diagnostic Testing and Knowledge Gaps.
(Boyanton BL Jr, Caldwell JM, Ledeboer NA.) J Infect Dis. 2024 Oct 23;230(Supplement_3):S182-S189 PMID: 39441195 PMCID: PMC11497843 SCOPUS ID: 2-s2.0-85207597145 10/23/2024
-
At-home testing for respiratory viruses: a minireview of the current landscape.
(Smy L, Ledeboer NA, Wood MG.) J Clin Microbiol. 2024 May 08;62(5):e0031223 PMID: 38436246 PMCID: PMC11077999 SCOPUS ID: 2-s2.0-85192677308 03/04/2024
-
New Sepsis Diagnostics and Their Impacts on Clinical Decision-Making and Treatment Protocols.
(Chambliss AB, Devaraj S, Hinson JS, Katz SE, Kerbel RB, Ledeboer NA.) Clin Chem. 2024 Feb 07;70(2):361-367 PMID: 38170198 SCOPUS ID: 2-s2.0-85184521588 01/04/2024
-
Validation of a Novel, Rapid Sepsis Diagnostic for Emergency Department Use.
(O'Neal HR Jr, Sheybani R, Janz DR, Scoggins R, Jagneaux T, Walker JE, Henning DJ, Rosenman E, Mahler SA, Regunath H, Sampson CS, Files DC, Fremont RD, Noto MJ, Schneider EE, Shealey WR, Berlinger MS, Carver TC, Walker MK, Ledeboer NA, Shah AM, Tse HTK, DiCarlo D, Rice TW, Thomas CB.) Crit Care Explor. 2024 Feb;6(2):e1026 PMID: 38333076 PMCID: PMC10852401 02/09/2024
-
(Kraus CK, O'Neal HR, Ledeboer NA, Rice TW, Self WH, Rothman RE.) J Pers Med. 2023 Dec 05;13(12) PMID: 38138912 PMCID: PMC10744443 12/23/2023